Home › Trial NCT01311232
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
- Trial IDNCT01311232
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorSamsung Medical Center
- Enrollment600
- Start date2010-11-01
- ConditionsPatients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma · Patients Treated With Rituximab-CHOP or Rituximab-CVP
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.